BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gonçalves IC, Henriques PC, Seabra CL, Martins MCL. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection. Expert Review of Anti-infective Therapy 2014;12:981-92. [DOI: 10.1586/14787210.2014.930663] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Maric T, Atladóttir S, Thamdrup LHE, Ilchenko O, Ghavami M, Boisen A. Self-propelled Janus micromotors for pH-responsive release of small molecule drug. Applied Materials Today 2022;27:101418. [DOI: 10.1016/j.apmt.2022.101418] [Reference Citation Analysis]
2 Ejaz S, Ejaz S, Shahid R, Noor T, Shabbir S, Imran M. Chitosan-curcumin complexation to develop functionalized nanosystems with enhanced antimicrobial activity against hetero-resistant gastric pathogen. Int J Biol Macromol 2022;204:540-54. [PMID: 35157901 DOI: 10.1016/j.ijbiomac.2022.02.039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lai Y, Wei W, Du Y, Gao J, Li Z. Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives. Gut Microbes 2022;14:2120747. [PMID: 36070564 DOI: 10.1080/19490976.2022.2120747] [Reference Citation Analysis]
4 Fonseca DR, Moura A, Leiro V, Silva-Carvalho R, Estevinho BN, Seabra CL, Henriques PC, Lucena M, Teixeira C, Gomes P, Parreira P, Martins MCL. Grafting MSI-78A onto chitosan microspheres enhances its antimicrobial activity. Acta Biomater 2022;137:186-98. [PMID: 34634508 DOI: 10.1016/j.actbio.2021.09.063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Cardos IA, Zaha DC, Sindhu RK, Cavalu S. Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies. Molecules 2021;26:6078. [PMID: 34641620 DOI: 10.3390/molecules26196078] [Reference Citation Analysis]
6 Mela I, Kaminski CF. Nano-vehicles give new lease of life to existing antimicrobials. Emerg Top Life Sci 2020;4:555-66. [PMID: 33258900 DOI: 10.1042/ETLS20200153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gómez-guillén MC, Montero MP. Enhancement of oral bioavailability of natural compounds and probiotics by mucoadhesive tailored biopolymer-based nanoparticles: A review. Food Hydrocolloids 2021;118:106772. [DOI: 10.1016/j.foodhyd.2021.106772] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
8 Lari AS, Zahedi P, Ghourchian H, Khatibi A. Microfluidic-based synthesized carboxymethyl chitosan nanoparticles containing metformin for diabetes therapy: In vitro and in vivo assessments. Carbohydr Polym 2021;261:117889. [PMID: 33766375 DOI: 10.1016/j.carbpol.2021.117889] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Iacob AT, Lupascu FG, Apotrosoaei M, Vasincu IM, Tauser RG, Lupascu D, Giusca SE, Caruntu ID, Profire L. Recent Biomedical Approaches for Chitosan Based Materials as Drug Delivery Nanocarriers. Pharmaceutics 2021;13:587. [PMID: 33924046 DOI: 10.3390/pharmaceutics13040587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mohamed NA, Abd El-Ghany NA, Abdel-Aziz MM. Synthesis, characterization, anti-inflammatory and anti-Helicobacter pylori activities of novel benzophenone tetracarboxylimide benzoyl thiourea cross-linked chitosan hydrogels. Int J Biol Macromol 2021;181:956-65. [PMID: 33878358 DOI: 10.1016/j.ijbiomac.2021.04.095] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Rashki S, Asgarpour K, Tarrahimofrad H, Hashemipour M, Ebrahimi MS, Fathizadeh H, Khorshidi A, Khan H, Marzhoseyni Z, Salavati-niasari M, Mirzaei H. Chitosan-based nanoparticles against bacterial infections. Carbohydrate Polymers 2021;251:117108. [DOI: 10.1016/j.carbpol.2020.117108] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
12 Sun X, Zhang S, Ren J, Udenigwe CC. Sialic acid-based strategies for the prevention and treatment of Helicobacter pylori infection: Emerging trends in food industry. Critical Reviews in Food Science and Nutrition. [DOI: 10.1080/10408398.2020.1846157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chouhan D, Mandal P. Applications of chitosan and chitosan based metallic nanoparticles in agrosciences-A review. Int J Biol Macromol 2021;166:1554-69. [PMID: 33181210 DOI: 10.1016/j.ijbiomac.2020.11.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Henriques PC, Costa LM, Seabra CL, Antunes B, Silva-Carvalho R, Junqueira-Neto S, Maia AF, Oliveira P, Magalhães A, Reis CA, Gartner F, Touati E, Gomes J, Costa P, Martins MCL, Gonçalves IC. Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice. Acta Biomater 2020;114:206-20. [PMID: 32622054 DOI: 10.1016/j.actbio.2020.06.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
15 Sami El-banna F, Mahfouz ME, Leporatti S, El-kemary M, A. N. Hanafy N. Chitosan as a Natural Copolymer with Unique Properties for the Development of Hydrogels. Applied Sciences 2019;9:2193. [DOI: 10.3390/app9112193] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
16 Cong Y, Geng J, Wang H, Su J, Arif M, Dong Q, Chi Z, Liu C. Ureido-modified carboxymethyl chitosan-graft-stearic acid polymeric nano-micelles as a targeted delivering carrier of clarithromycin for Helicobacter pylori: Preparation and in vitro evaluation. International Journal of Biological Macromolecules 2019;129:686-92. [DOI: 10.1016/j.ijbiomac.2019.01.227] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
17 Agarwal H, Nakara A, Shanmugam VK. Anti-inflammatory mechanism of various metal and metal oxide nanoparticles synthesized using plant extracts: A review. Biomedicine & Pharmacotherapy 2019;109:2561-72. [DOI: 10.1016/j.biopha.2018.11.116] [Cited by in Crossref: 80] [Cited by in F6Publishing: 48] [Article Influence: 26.7] [Reference Citation Analysis]
18 Seabra CL, Nunes C, Brás M, Gomez-lazaro M, Reis CA, Gonçalves IC, Reis S, Martins MCL. Lipid nanoparticles to counteract gastric infection without affecting gut microbiota. European Journal of Pharmaceutics and Biopharmaceutics 2018;127:378-86. [DOI: 10.1016/j.ejpb.2018.02.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery. Pharmaceutics 2017;9:E53. [PMID: 29156634 DOI: 10.3390/pharmaceutics9040053] [Cited by in Crossref: 361] [Cited by in F6Publishing: 273] [Article Influence: 72.2] [Reference Citation Analysis]
20 Zaidi S, Misba L, Khan AU. Nano-therapeutics: A revolution in infection control in post antibiotic era. Nanomedicine 2017;13:2281-301. [PMID: 28673854 DOI: 10.1016/j.nano.2017.06.015] [Cited by in Crossref: 78] [Cited by in F6Publishing: 56] [Article Influence: 15.6] [Reference Citation Analysis]
21 Seabra CL, Nunes C, Gomez-lazaro M, Correia M, Machado JC, Gonçalves IC, Reis CA, Reis S, Martins MCL. Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori. International Journal of Pharmaceutics 2017;519:128-37. [DOI: 10.1016/j.ijpharm.2017.01.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
22 Dayem AA, Choi HY, Yang GM, Kim K, Saha SK, Kim JH, Cho SG. The potential of nanoparticles in stem cell differentiation and further therapeutic applications. Biotechnol J 2016;11:1550-60. [PMID: 27797150 DOI: 10.1002/biot.201600453] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
23 Gonçalves IC, Magalhães A, Costa AM, Oliveira JR, Henriques PC, Gomes P, Reis CA, Martins MC. Bacteria-targeted biomaterials: Glycan-coated microspheres to bind Helicobacter pylori. Acta Biomater 2016;33:40-50. [PMID: 26805428 DOI: 10.1016/j.actbio.2016.01.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
24 Zazo H, Colino CI, Lanao JM. Current applications of nanoparticles in infectious diseases. J Control Release 2016;224:86-102. [PMID: 26772877 DOI: 10.1016/j.jconrel.2016.01.008] [Cited by in Crossref: 173] [Cited by in F6Publishing: 144] [Article Influence: 28.8] [Reference Citation Analysis]
25 Cao C, Yan C, Hu Z, Zhou S. Potential application of injectable chitosan hydrogel treated with siRNA in chronic rhinosinusitis therapy. Mol Med Rep 2015;12:6688-94. [PMID: 26299569 DOI: 10.3892/mmr.2015.4237] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]